Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Abstract: See the related article at Neutrophil-progenitor feedback sustains splenic myelopoiesis and promotes immune evasion in cancer

See the related article at Neutrophil-progenitor feedback sustains splenic myelopoiesis and promotes immune evasion in cancer.

Address for correspondence. Hongpeng Jia, Division of Pediatric Surgery, Department of Surgery, Johns Hopkins University School of Medicine, 1721 E. Madison Street, Baltimore, Maryland, 21,208, USA. Email: [email protected].

Commonly used drug kills leukemia cells early by acting mainly on RNA, not DNA

For more than two decades, azacitidine has been a major treatment for blood cancers such as high-risk myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). The drug was thought to work through DNA, by stripping off the chemical tags that keep genes silenced and allowing those genes to switch back on.

Understanding how azacitidine works matters because the drug helps only a third to half of patients, and doctors have no reliable way to predict who will benefit.

In a recent study published in Molecular Cell, researchers at the University of Chicago and UT Health San Antonio report that during the first day of treatment, when the drug kills the most cancer cells, almost none of it happens in DNA, but instead mostly in RNA. There, it strips chemical tags from RNA and shuts down genes that cancer cells need to divide and repair their DNA. The research findings point to NSUN2, the enzyme that installs those tags, as a more precise drug target.

Dual-purpose polymer dots could combine bioimaging and light-triggered cell death in one material

A research team led by professor Youhei Takeda at the University of Osaka, in collaboration with professor Zachary M. Hudson at the University of British Columbia (UBC) in Canada, has developed a polymer material that combines fluorescent cell imaging with the potential to kill cancer cells when activated by light. The material could offer a simpler approach to developing “nanotheranostic” technologies, which bring disease imaging and treatment together in a single platform.

Nanotheranostic materials are challenging to develop because one material must accommodate the different demands of both imaging and therapy.

Immortalism, Deathism, Healthspan, and Survival

This intense and stimulating discussion between Kai Micah Mills, Aubrey de Grey, and Max More begins by investigating claims made by Kai at his Vitalist Bay talk. In particular, his claim that there is a retreat from immortalism and hardcore life extension advocacy. Max and Aubrey agree and disagree with elements of his claim. We discuss the immortalism in Russian Cosmism, the similarities in the thought of Frank Tipler and Mormon church, and raise the possibility that past people do not want to be resurrected. Also discussed:

Bacterial toxin produced by E coli leading suspect in rise in bowel cancer among under-50s

Exposure to a bacterial toxin in early life has emerged as a leading suspect in the rise of bowel cancer among those under 50, MPs have heard.

Cases of early-onset bowel cancer have doubled in many countries in the past two decades, and while rising obesity and a fall in physical activity are contributors, researchers believe other factors must also be involved.

Dr Karl Smith-Byrne, a senior molecular epidemiologist at the University of Oxford, told the Commons science and technology committee that known risk factors for colorectal cancer, such as obesity, smoking and alcohol, can explain only about half of the cases doctors diagnose.

Psilocybin decreases neural responsiveness and increases functional connectivity while preserving pure-tone frequency selectivity in mouse auditory cortex

Psilocybin is a serotonergic psychedelic believed to have therapeutic potential for neuropsychiatric conditions. Despite well-documented prevalence of perceptual alterations, hallucinations, and synesthesia associated with psychedelic experiences, little is known about how psilocybin affects sensory cortex or alters the activity of neurons in awake animals. To investigate, we conducted two-photon imaging experiments in auditory cortex of awake mice and collected video of free-roaming mouse behavior, both at baseline and during psilocybin treatment. In comparison with pre-dose neural activity, a 2 mg/kg ip dose of psilocybin initially increased the amplitude of neural responses to sound. Thirty minutes post-dose, behavioral activity and neural response amplitudes decreased, yet functional connectivity increased. In contrast, control mice given intraperitoneal saline injections showed no significant changes in either neural or behavioral activity across conditions. Notably, neuronal stimulus selectivity remained stable during psilocybin treatment, for both tonotopic cortical maps and single-cell pure-tone frequency tuning curves. Our results mirror similar findings regarding the effects of serotonergic psychedelics in visual cortex and suggest that psilocybin modulates the balance of intrinsic versus stimulus-driven influences on neural activity in auditory cortex.

NEW & NOTEWORTHY Recent studies have shown promising therapeutic potential for psychedelics in treating neuropsychiatric conditions. Musical experience during psilocybin-assisted therapy is predictive of treatment outcome, yet little is known about how psilocybin affects auditory processing. Here, we conducted two-photon imaging experiments in auditory cortex of awake mice that received a dose of psilocybin. Our results suggest that psilocybin modulates the roles of intrinsic neural activity versus stimulus-driven influences on auditory perception.

Levent Alpöge

Who is the mathematician behind the Riemann Hypothesis claim—and why is the math world paying close attention?

Following the bombshell announcement that he and Claude may have cracked—and formalized in Lean 4—the 167-year-old Riemann Hypothesisv(along with the Generalized Riemann Hypothesis), many have been asking: Who is Levent Alpöge? And where is the paper?

If you look at his track record, this isn’t an outsider making a random claim. Alpöge is one of the brightest number theorists of his generation—and he has spent 2026 at the epicenter of AI-assisted mathematical discovery:

🎓 Deep Pedigree in Pure Math:

* Earned his PhD in Mathematics from Princeton under Fields Medalist Manjul Bhargava (2020), after completing degrees at Harvard (graduating *summa cum laude* with a 4.0 GPA and winning the Morgan Prize) and Cambridge.

* Served as a Junior Fellow in the Harvard Society of Fellows (2021–2025), specializing in number theory, arithmetic statistics, and elliptic curves—and even co-authored major work proving Hilbert’s tenth problem is undecidable over the ring of integers of any number field.

🤖 From Pure Math to AI-Assisted Breakthroughs:

Anthropic mathematician claims to prove Riemann hypothesis, most famous problem in all of math

Levent Alpöge, a mathematician and employee at artificial intelligence company Anthropic, claimed on Friday to have proven the most famous problem in all of mathematics using a large language model.

“I believe I have, working with Claude, discovered a proof of the Riemann Hypothesis,” Alpöge wrote in a statement posted on his website.

The Riemann hypothesis was first proposed in 1859 by mathematician Bernhard Riemann and has since become the North Star for the entire field of number theory. An artificial-intelligence-generated solution of the 167-year-old problem, long considered far out of reach to human mathematicians, would cap off the technology’s year-long conquest of math in spectacular fashion.


An AI-generated solution of the 167-year-old problem, long considered far out of reach to human mathematicians, would cap off the technology’s year-long conquest of math in spectacular fashion.

By Joseph Howlett edited by Claire Cameron.